PATENT CLAIM ANALYSIS

Application Number: 15907040
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-02
Patent Classification: ["546", "169000"]

Abstract:
The invention relates to novel heteroaryl carboxamides, processes for their preparation, and their use for producing medicaments for the treatment and/or prophylaxis of diseases and for improving perception, concentration, learning and/or memory.

Claim (Index 12):
The method of  claim 10 , wherein the cognitive impairment is schizophrenia.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 88.0
- Lexical Diversity: 1.32143
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11891527', '10496404', '14833987', '13544321', '14299750']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7898025274867898
- 35 USC 102 Novelty (BERT): 0.5556920947498057
- Combined Prediction Score: 0.7663914842130914
- Mean Citation Score: 356.92741800000016
- Max Citation Score: 413.72452
- Similarity Product: 360.8126537832642

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test